Pilulka Lekarny AS (XPRA:PINK) EPS (Basic): Kč0.00 (TTM As of Dec. 2025)


XPRA:PINK Pilulka Lekarny AS XPRA:PINK
49 GF Score
Price Kč120.00
GF Value Kč114.76
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pilulka Lekarny AS EPS (Basic)?

Pilulka Lekarny AS XPRA:PINK +0.84% 49 EPS (Basic) is Kč0.00 as of Dec. 2025. GuruFocus rates XPRA:PINK with a GF Score™ of 49/100 and a GF Value™ of Kč114.76 (Fairly Valued). The stock has 6 warning signs investors should review.

Pilulka Lekarny AS's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was Kč0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was Kč0.00.

Pilulka Lekarny AS's EPS (Diluted) for the six months ended in Dec. 2025 was Kč0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was Kč0.00.

Pilulka Lekarny AS's EPS without NRI for the six months ended in Dec. 2025 was Kč0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 19.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was -30.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Pilulka Lekarny AS's highest 3-Year average EPS without NRI Growth Rate was 19.50% per year. The lowest was -100.60% per year. And the median was -92.60% per year.

Pilulka Lekarny AS  (XPRA:PINK) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Pilulka Lekarny AS EPS (Basic) Related Terms

Pilulka Lekarny AS EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Pilulka Lekarny AS's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pilulka Lekarny AS EPS (Basic) Chart

Pilulka Lekarny AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial -10.09 -25.49 -64.63 -46.46 -14.36

Pilulka Lekarny AS Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Jun24 Dec24 Dec25
EPS (Basic) Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
XPRA:PINK
49GF Score
Pilulka Lekarny AS XPRA:PINK
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pilulka Lekarny AS EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Pilulka Lekarny AS's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-38.869-0)/2.707
=-14.36

Pilulka Lekarny AS's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0-0)/2.707
=0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was Kč0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of Kč0.00 mean?
Pilulka Lekarny AS (XPRA:PINK) has a EPS (Basic) of Kč0.00 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Pilulka Lekarny AS and its competitors.
Is Pilulka Lekarny AS's EPS (Basic) too high?
Pilulka Lekarny AS's current EPS (Basic) is Kč0.00. Overall, Pilulka Lekarny AS has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's EPS (Basic) compare to competitors?
Pilulka Lekarny AS's EPS (Basic) of Kč0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Pilulka Lekarny AS and its competitors. Pilulka Lekarny AS's current EPS (Basic) is Kč0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Fairly Valued. The stock's GF Value™ is Kč114.76, compared to a current price of Kč120.00 — trading 4.6% above its estimated fair value. The current EPS (Basic) is Kč0.00. Pilulka Lekarny AS's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current EPS (Basic) is Kč0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?

Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be overvalued. The current stock price of Kč120.00 is trading 4.6% above its estimated GF Value™ of Kč114.76. GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.

Key valuation signals for XPRA:PINK:

  • EPS (Basic): Kč0.00
  • GF Value™: Kč114.76 vs. price of Kč120.00 (4.6% above fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pilulka Lekarny AS Business Description

Address Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
49GF Score

Get the complete analysis for XPRA:PINK

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Kč120.00
Price
Kč114.76
GF Value